# K022741: Spot Pro (220V), Model 131.099

- Pathway: 510(k) (Special)
- Applicant: Nucletron Corporation
- Decided: Oct 24, 2002 after 66 days
- Product code: MUJ (System, Planning, Radiation Therapy Treatment)
- Device class: 2
- Regulation: 21 CFR 892.5050
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K911612 (1991). 3 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K992303: Sonographic Planning of Oncology Treatments (Spot), Model V.. 1.0, Nucletron Corp. (2000) Summary page 2.

## Most influential descendants
- K112420: Oncentra Prostate 4.0 (2011), 1 descendant of its own
- K170841: BiopSee, Mobile US (2017), 0 descendants of its own

## Indications for use
SPOT PRO is a software application for Brachytherapy Treatment Planning, for the treatment of cancer, i.e. intercavitary, interstitial, intraluminal, involving radioactive sources.

Source page: https://510kreport.com/device/K022741
Methodology: https://510kreport.com/methodology